Stride, Inc. (NYSE: LRN) director reports 4,097-share restricted stock grant

Rhea-AI Filing Summary

Stride, Inc. reported an equity grant to one of its directors. On December 4, 2025, the director acquired 4,097 shares of Stride common stock at a price of $0, reflecting a restricted stock award rather than an open-market purchase. Following this transaction, the director beneficially owns 42,201 shares, held directly.

The new shares are restricted and will vest on the earlier of December 4, 2026 or the date of the next annual meeting of Stride, Inc. stockholders. This filing is a routine Form 4 disclosure of director equity compensation and does not describe any broader corporate events or financial results.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ALVAREZ AIDA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,097	$0.00	--

Holdings After Transaction: Common Stock — 42,201 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ALVAREZ AIDA

(Last) (First) (Middle)

11720 PLAZA AMERICA DRIVE

9TH FLOOR

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Stride, Inc. [ LRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/04/2025		A		4,097(1)	A	$0	42,201	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares are restricted and will vest on the earlier of (a) December 4, 2026, or (b) the next annual meeting of the stockholders of Stride, Inc.

	/s/ John C. Grothaus, Attorney-in-fact	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Stride, Inc. (LRN) disclose in this Form 4?

A Stride, Inc. director received a grant of 4,097 shares of common stock on December 4, 2025 as reported in this Form 4.

How many Stride, Inc. (LRN) shares does the director own after this transaction?

After the reported grant, the director beneficially owns 42,201 shares of Stride, Inc. common stock, held directly.

What was the price for the 4,097 Stride (LRN) shares reported in the Form 4?

The 4,097 shares of Stride common stock were reported at a price of $0, indicating a restricted stock award rather than a market purchase.

When do the restricted Stride, Inc. (LRN) shares reported in the Form 4 vest?

The restricted shares will vest on the earlier of December 4, 2026 or the date of the next annual meeting of Stride, Inc. stockholders.

What is the reporting person’s relationship to Stride, Inc. (LRN)?

The reporting person is a director of Stride, Inc., as indicated in the relationship section of the filing.

Is this Stride, Inc. (LRN) Form 4 filed by one person or a group?

The Form 4 is filed by one reporting person, not by a group, according to the filing election.